Yinhua CSI Traditional Chinese Medicine Exchange ETF (SHA:562390)

Assets	n/a
Expense Ratio	0.60%
PE Ratio	19.93
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-13.96%

Volume	988,400
Open	0.8590
Previous Close	0.8580
Day's Range	0.8560 - 0.8630
52-Week Low	0.7720
52-Week High	1.0600
Beta	0.20
Holdings	41
Inception Date	Jul 20, 2022

About 562390

562390.SS was created on 2022-07-20 by Yinhua. The fund's investment portfolio concentrates primarily on health care equity. The fund adopts passive index investment, closely tracks the target index, and pursues tracking deviation and tracking error.difference is minimized

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 562390
• Provider: Yinhua
• Index Tracked: CSI Traditional Chinese Medicine Index - CNY - Benchmark TR Gross

Performance

562390 had a total return of -13.96% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.51%.

Top 10 Holdings

57.06% of assets

Name	Symbol	Weight
Yunnan Baiyao Group Co.,Ltd	000538	9.98%
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.	600436	9.57%
Dong-E-E-Jiao Co., Ltd.	000423	6.28%
Jilin Aodong Pharmaceutical Group Co., Ltd.	000623	5.21%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	002317	5.13%
Beijing Tongrentang Co., Ltd	600085	4.87%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	000999	4.60%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited	600332	4.33%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.	002603	3.85%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	600329	3.26%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error